In a long-overdue appearance, Saurabh Jha, MD, radiologist in Philadelphia, makes his triumphant return to the show to pick apart the single-payer model idea as well as FDA regulatory processes, this time with a worthy adversary: Adam Gaffney, MD, MPH, pulmonary specialist and health policy researcher at Cambridge Health Alliance/Harvard Medical School. The conversation begins with discussion of a proposed federal single-payer system in America, why it could not be modeled after a successful system like that in England, why significant health disparities exist geographically within a single-payer system and whether such a system can provide the tools to address these disparities, and so much more. Then, the conversation swings to whether a health care system should be designed to afford high-priced novel therapies because of failure to regulate these prices, on what basis the FDA should approve drugs, and other points of discussion. Things get testy in this spirited back-and-forth banter and you won’t want to miss it.
N/A
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
